Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

After 10 Years, US FDA ‘Additional Conditions’ Proposed Rule Offers ‘Novel Switch’ Pathway

Jun 28 2022

• By Hannah Daniel

• Source: Shutterstock

Related Content

FDA Aims To “NSURE” Clarity About New Paradigm For OTC Switches

Nov 05 2012

FDA Considers “New Paradigm” To Switch More Rx Drugs

Feb 27 2012

Expanding US OTC Switches Turns On Flexibility In FDA Drug Approval Process And For Consumers

Jun 28 2022

Making Progress On Novel OTC Switch Rulemaking Has FDA Commissioner Nominee Califf’s Attention

Jan 12 2022

Facilitating More OTC Switches In US Graduates To Regulatory Plan On FDA’s Unified Agenda

Jan 03 2022

FDA Plans To Publish 'Novel' OTC Switch NPRM In May 2020

Nov 22 2019

Before Asking FDA For Novel OTC Switch, Be Sure DFL Alone 'Can't Get There'

May 23 2019

Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance

Jul 17 2018

Additional Topics

International United States FDA Prescription To OTC Switch Regulation Advertising, Marketing & Sales Business Strategies Commercial Compliance Consumer Drug Approval Standards Drug Review Drug Safety Enforcement Guidance Documents Ingredients Manufacturing OTC Drugs Policy Politics Supply Chain

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window